DPP8/9 Inhibition Attenuates the TGF-β1-induced Excessive Deposition of Extracellular Matrix (ECM) in Human Mesangial Cells Via Smad and Akt Signaling Pathways

Ke Li,Yuzhan Zhang,Weihao Zhao,Rongrong Wang,Yan Li,Linting Wei,Li Wang,Xianghui Chen,Zhao Chen,Pengfei Liu,Na Nie,Xuefei Tian,Rongguo Fu
DOI: https://doi.org/10.1016/j.toxlet.2024.03.001
IF: 4.271
2024-01-01
Toxicology Letters
Abstract:The pathogenesis of glomerular diseases is strongly influenced by abnormal extracellular matrix (ECM) deposition in mesangial cells. Dipeptidyl peptidase IV (DPPIV) enzyme family contains DPP8 and DPP9, which are involved in multiple diseases. However, the pathogenic roles of DPP8 and DPP9 in mesangial cells ECM deposition remain unclear. In this study, we observed that DPP8 and DPP9 were significantly increased in glomerular mesangial cells and podocytes in CKD patients compared with healthy individuals, and DPP9 levels were higher in the urine of IgA nephropathy (IgAN) patients than in control urine. Therefore, we further explored the mechanism of DPP8 and DPP9 in mesangial cells and revealed a significant increase in the expression of DPP8 and DPP9 in human mesangial cells (HMCs) following TGF-β1 stimulation. Silencing DPP8 and DPP9 by siRNAs alleviated the expression of ECM-related proteins including collagen Ⅲ, collagen Ⅳ, fibronectin, MMP2, in TGF-β1-treated HMCs. Furthermore, DPP8 siRNA and DPP9 siRNA inhibited TGF-β1-induced phosphorylation of Smad2 and Smad3, as well as the phosphorylation of Akt in HMCs. The findings suggested the inhibition of DPP8/9 may alleviate HMCs ECM deposition induced by TGF-β1 via suppressing TGF-β1/Smad and AKT signaling pathways.
What problem does this paper attempt to address?